Prospective Markers for Early Diagnosis and Prognosis of Sporadic Pancreatic Ductal Adenocarcinoma

被引：0
|
作者：
Martin Tobi
Mijin Kim
Douglas H. Weinstein
Mary Ann Rambus
James Hatfield
N. Volkan Adsay
Edi Levi
Douglas Evans
Michael J. Lawson
Suzanne Fligiel
机构：
[1] Philadelphia Veterans Affairs Medical Center,Gastroenterology Section
[2] University of Pennsylvania School of Medicine,Division of Gastroenterology, Department of Medicine
[3] Wayne State University School of Medicine,Department of Medicine and Pathology, John D. Dingell Veterans Affairs Medical Center
[4] M.D. Anderson Cancer Center,Kaiser Permanente
[5] University of California,undefined
来源：
Digestive Diseases and Sciences | 2013年 / 58卷
关键词：
Pancreatic ductal adenocarcinoma (PDA); Adnab-9 monoclonal antibody; K-; Her-2/;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：744 / 750
页数：6
相关论文
共 50 条
  • [1] Prospective Markers for Early Diagnosis and Prognosis of Sporadic Pancreatic Ductal Adenocarcinoma
    Tobi, Martin
    Kim, Mijin
    Weinstein, Douglas H.
    Rambus, Mary Ann
    Hatfield, James
    Adsay, N. Volkan
    Levi, Edi
    Evans, Douglas
    Lawson, Michael J.
    Fligiel, Suzanne
    DIGESTIVE DISEASES AND SCIENCES, 2013, 58 (03) : 744 - 750
  • [2] Major Molecular Markers in Pancreatic Ductal Adenocarcinoma and Their Roles in Screening, Diagnosis, Prognosis, and Treatment
    Singh, Puneet
    Srinivasan, Radhika
    Wig, Jai Dev
    PANCREAS, 2011, 40 (05) : 644 - 652
  • [3] Possible Molecular Markers for the Diagnosis of Pancreatic Ductal Adenocarcinoma
    Shen, Quan
    Yu, Miao
    Jia, Jiang-Kun
    Li, Wen-Xi
    Tian, Yu-Wei
    Xue, Huan-Zhou
    MEDICAL SCIENCE MONITOR, 2018, 24 : 2368 - 2376
  • [4] Identification of novel predictive markers for the prognosis of pancreatic ductal adenocarcinoma
    Luo, Yanli
    Qiu, Zhengjun
    Tian, Ling
    Zhu, Guanghui
    Feng, Ye
    Yi, Miaoying
    Chen, Xiafang
    Wang, Liwei
    Li, Chuanyuan
    Huang, Qian
    HUMAN PATHOLOGY, 2013, 44 (01) : 69 - 76
  • [5] Global histone modifications as markers of pancreatic ductal adenocarcinoma prognosis
    Lu, Y.
    Kim, L.
    Frederick, B.
    Zhang, M.
    Liao, J.
    Talamonti, M.
    Bentrem, D.
    Rao, S. M.
    Yang, G. Y.
    LABORATORY INVESTIGATION, 2008, 88 : 310A - 310A
  • [6] Global histone modifications as markers of pancreatic ductal adenocarcinoma prognosis
    Lu, Y.
    Kim, L.
    Frederick, B.
    Zhang, M.
    Talamonti, M.
    Bentrem, D.
    Rao, S. M.
    Yang, G. Y.
    MODERN PATHOLOGY, 2008, 21 : 310A - 310A
  • [7] Identification of Novel Predictive Markers for the Prognosis of Pancreatic Ductal Adenocarcinoma
    Jiang, Bing
    Gu, Yonghong
    Chen, Yuxiang
    CANCER INVESTIGATION, 2014, 32 (06) : 218 - 225
  • [8] The role of miRNAs in the diagnosis, chemoresistance, and prognosis of pancreatic ductal adenocarcinoma
    Ren, Le
    Yu, Yue
    THERAPEUTICS AND CLINICAL RISK MANAGEMENT, 2018, 14 : 179 - 187
  • [9] Early Detection of Sporadic Pancreatic Ductal Adenocarcinoma: Problems, Promise, and Prospects
    Chari, Suresh T.
    Sharma, Ayush
    Maitra, Anirban
    ANNALS OF INTERNAL MEDICINE, 2020, 172 (08) : 558 - +
  • [10] Comparison of Prognostic Markers for Patients' Prognosis in Advanced Pancreatic Ductal Adenocarcinoma
    Suzuki, Rei
    Takagi, Tadayuki
    Hikichi, Takuto
    Watanabe, Ko
    Sugimoto, Mitsuru
    Waragai, Yuichi
    Kikuchi, Hitomi
    Asama, Hiroyuki
    Takasumi, Mika
    Ohira, Hiromasa
    GASTROENTEROLOGY, 2016, 150 (04) : S324 - S324
12345